Strata Critical Medical, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $4.83
- 52-Week Range
- $3.95 – $6.50
- Market Cap
- $418.45M
- P/E (TTM)
- —
- EPS (TTM)
- -0.28
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.50
- PEG Ratio
- —
- Return on Equity
- -9.22%
- Return on Assets
- -1.86%
- Gross Margin
- 21.25%
- Operating Margin
- -6.32%
- Profit Margin
- 15.71%
- Current Ratio
- 2.64
- Debt/Equity
- 0.02
- Total Debt
- $4.25M
- Free Cash Flow
- $-20.09M
- Revenue Growth
- 60.70%
- Earnings Growth
- —
- Enterprise Value
- $399.95M
Market Snapshot
About
Strata Critical Medical, Inc. is a medical device company focused on developing and commercializing innovative spinal fusion products. The company specializes in biomaterials and technologies designed to improve outcomes in spinal surgery. Its products are designed to address the challenges of bone healing and fusion in complex spinal procedures.